|Articles|April 8, 2012
What Does Overturning ACA Mean to Pharma?
Author(s)Christopher Allen
In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation.
Advertisement
Guest blog written by Reid Paul.
In contentious three days of hearing on the Affordable Care Act, the Supreme Court now seems far more likely to overturn the landmark legislation. Given the strong support the bill originally received from the industry, does overturning it benefit or hurt pharma?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
A Capsule-in-Capsule Platform for Multi-Phase Release of Liquid and Solid Formulations
2
PharmTech Explained: China's Biotech Rise Signals New Risks for US Manufacturers
3
Europe Tried to Ban Generative AI From Critical GMP. The Ban May Not Survive. It Does Not Matter.
4
Q&A: Sterile Injectable Manufacturers Gain New CDMO Option as Halo Expands
5